🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial will evaluate the efficacy and safety of brivaracetam (at doses ...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT00175929
Treatments Being Tested
To evaluate if Brivaracetam (BRV) influences the psychomotor and cognitive ...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01710670
Treatments Being Tested
The purpose of the study is to evaluate the efficacy of brivaracetam (BRV) ...
Status
Completed
Location
Ep0083 905
Start Date
2017-08-22
Trial ID
NCT03083665
Treatments Being Tested
This is a multicenter, open-label, 4-arm, randomized, parallel-group study ...
Status
Completed
Location
001
Start Date
2011-08
Trial ID
NCT01405508
Treatments Being Tested
The primary objective of the study is to evaluate the neurocognitive effect...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT00736931
Treatments Being Tested
This study will evaluate the efficacy and safety of Brivaracetam to support...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00464269
Treatments Being Tested
This study will evaluate the efficacy and safety of Brivaracetam to support...
Status
Completed
Location
13
Start Date
2007-09
Trial ID
NCT00490035
Treatments Being Tested
Ιn the present study (BIOEPI), the following three hypotheses will be inves...
Status
Unknown
Location
Prof. Vasilios Kimiskidis
Start Date
2022-08-01
Trial ID
NCT05278221
Treatments Being Tested
to assess the effect of brivaracetam on the photoparoxysmal EEG response in...
Status
Completed
Location
Multiple Locations
Start Date
2002-09
Trial ID
NCT00401648
Treatments Being Tested
Spinal cord injury (SCI) is associated with severe neuropathic pain that is...
Status
Completed
Location
University of Minnesota
Start Date
2023-01-01
Trial ID
NCT05639946
Treatments Being Tested